Drawing for GREENLIGHT BIOSCIENCES

USPTO serial 98241704

GREENLIGHT BIOSCIENCES

Reviewed by CopyMark Law Group

Status 645Office Action
Filing date
Status date
Registration date
—
Examiner
EULIN, INGRID C
Law office
TMEG LAW OFFICE 105

What this means

The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.

Status 645: Status 645 means the USPTO mailed a final refusal maintaining at least one objection to your application. You can respond, appeal to the Trademark Trial and Appeal Board, or allow the application to abandon.

Need help with GREENLIGHT BIOSCIENCES?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Rachelle A. Dubow, Esq.

Rachelle A. Dubow, Esq. MORGAN, LEWIS & BOCKIUS LLPONE FEDERAL STREETBOSTON, MA 02110United States

Goods and services

ClassDescriptionStatusFirst use
001Chemical reagents and RNA sequences being chemical reagents for agricultural purposes, and not medical or veterinary purposes, namely, for crop protection and to improve plant health and plant yield; chemical treatments applied to seeds, plants and crops to improve plant health and yieldACTIVE—
005Chemical reagents and RNA sequences being chemical reagents used to repel or destroy insects, pests, parasites, and vermin; Agricultural products, namely, insecticides, pesticides, fungicides; preparations for destroying vermin; Chemical reagents and RNA sequences being chemical reagents used for improving bee health; Pharmaceutical products and veterinary products for human and animal health in the nature of vaccines and RNA therapeutics for the treatment of parasitic infection or infestations, infectious diseases, neurological diseases, metabolic diseases, cardiovascular diseases, respiratory diseases, immune system diseases, and cancer; Antibiotics; Vaccines; Gene therapy products, namely, mRNA therapeutics and siRNA therapeutics for medical or clinical use for the treatment of infectious diseases, respiratory diseases, immune system diseases, cardiovascular diseases, and cancer; RNA in the nature of vaccines and therapeutics for scientific, research, medical, pharmaceutical, veterinary, agricultural, industrial and manufacturing use for the treatment of infectious diseases, neurological diseases, metabolic diseases, cardiovascular diseases, respiratory diseases, immune system diseases, parasitic infection or infestation, and cancerACTIVE—
040Cell-Free processing and manufacturing of RNA for others; biological manufacturing and cell-free processing of RNA for othersACTIVE—
042Research and development services in the field of RNA for scientific, engineering, research, medical, pharmaceutical, veterinary, agricultural, chemical and energy production, industrial and manufacturing use; research and development services in the field of synthetic and recombinant biology and formulations; design and engineering in the field of producing RNA and cell-free processing; research and development services in the field of producing, manufacturing, and processing of RNA and RNA formulations for scientific, research, medical, pharmaceutical, veterinary, agricultural food, chemical and energy production, industrial and manufacturing use; research and development services in the field of formulations for the delivery of RNA for scientific, research, medical, pharmaceutical, veterinary, agricultural, chemical and energy production, industrial and manufacturing useACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 13, 2026GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Oct 13, 2026GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Oct 13, 2026CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 30, 2026RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Mar 2, 2026GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Mar 2, 2026GNSLLETTER OF SUSPENSION E-MAILED—
Mar 2, 2026CNSLSUSPENSION LETTER WRITTEN—
Feb 18, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 18, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 18, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 17, 2025XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Nov 17, 2025XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Aug 18, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 18, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 18, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 27, 2025RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Nov 26, 2024GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Nov 26, 2024GNSLLETTER OF SUSPENSION E-MAILED—
Nov 26, 2024CNSLSUSPENSION LETTER WRITTEN—
Nov 25, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 25, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 25, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 5, 2024XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Sep 5, 2024XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Jun 26, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 26, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jun 26, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jun 7, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 7, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 7, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 6, 2024DOCKASSIGNED TO EXAMINER—
Nov 1, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 30, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance